Larson Financial Group
ANVS icon

Larson Financial Group’s Annovis Bio ANVS Stock Holding History

Larson Financial Group’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$381 Hold
300
– – ﹤0.01% 3634
2026
Q2 		$558 Hold
300
– – ﹤0.01% 3465
2026
Q1 		$669 Hold
300
– – ﹤0.01% 3258
2025
Q4 		$1.04K Hold
300
– – ﹤0.01% 2942
2025
Q3 		$621 Hold
300
– – ﹤0.01% 3052
2025
Q2 		$651 Buy
300
+150
+100% +$296 ﹤0.01% 2780
2025
Q1 		$225 Buy
+150
New +$459 ﹤0.01% 2767

Other funds holding ANVS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
SG
Sherry Group Mountain Home, Arkansas $107M AUM 11.17% 1-Year Est. Return
Greenwich Wealth Management
Greenwich Wealth Management Greenwich, Connecticut $3.09B AUM 22.23% 1-Year Est. Return
Wescott Financial Advisory Group
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.36B AUM 14.05% 1-Year Est. Return
CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
Sterling Investment Advisors (Pennsylvania)
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $606M AUM 21.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Larson Financial Group's ANVS Position: Q3 2026 in Review

Larson Financial Group held its Annovis Bio (ANVS) position steady in Q3 2026 at 300 shares worth $381. The position accounts for ﹤0.01% of the portfolio, ranked #3634.

Larson Financial Group first reported a position in ANVS in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.04K in Q4 2025. 35 funds tracked by Wall St. Rank hold ANVS as of Q3 2026.

  • Larson Financial Group held 300 shares of Annovis Bio worth $381 as of Q3 2026.
  • Larson Financial Group left its Annovis Bio share count unchanged in Q3 2026.
  • Annovis Bio made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3634 holding.
  • Larson Financial Group first reported a position in Annovis Bio in Q1 2025 and has held it in 7 quarters since.
  • Larson Financial Group's Annovis Bio position peaked at $1.04K in Q4 2025.
  • 35 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.